Listed

ARS Pharmaceuticals, Inc.

SPRYNasdaqCIK 1671858HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$33.7m, Q2 FY2026
Operating income−$61.5m, Q2 FY2026
Net income−$62.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure0.5Revenue, Q2 FY2024, three months to 2024-06-30$500.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure2.1Revenue, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure86.6Revenue, Q4 FY2024, three months to 2024-12-31$86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure8.0Revenue, Q1 FY2025, three months to 2025-03-31$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure15.7Revenue, Q2 FY2025, three months to 2025-06-30$15.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure32.5Revenue, Q3 FY2025, three months to 2025-09-30$32.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure28.1Revenue, Q4 FY2025, three months to 2025-12-31$28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure22.7Revenue, Q1 FY2026, three months to 2026-03-31$22.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure33.7Revenue, Q2 FY2026, three months to 2026-06-30$33.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Research and development$m3.0Research and development, Q3 FY2023, three months to 2023-09-30$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure3.4Research and development, Q4 FY2023, three months to 2023-12-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure5.2Research and development, Q1 FY2024, three months to 2024-03-31$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure6.9Research and development, Q2 FY2024, three months to 2024-06-30$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure4.4Research and development, Q3 FY2024, three months to 2024-09-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure3.0Research and development, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure3.0Research and development, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure4.0Research and development, Q2 FY2025, three months to 2025-06-30$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure2.8Research and development, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure3.4Research and development, Q4 FY2025, three months to 2025-12-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure4.3Research and development, Q1 FY2026, three months to 2026-03-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure4.7Research and development, Q2 FY2026, three months to 2026-06-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Selling, general and administrative$m15.0Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$15.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure6.8Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$6.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure8.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$8.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure8.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$8.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure19.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$19.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure35.5Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$35.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure41.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$41.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure54.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$54.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure74.8Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$74.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure60.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$60.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure72.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$72.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure77.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$77.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Operating income$m(18.0)Operating income, Q3 FY2023, three months to 2023-09-30−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure(10.2)Operating income, Q4 FY2023, three months to 2023-12-31−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure(13.2)Operating income, Q1 FY2024, three months to 2024-03-31−$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure(15.3)Operating income, Q2 FY2024, three months to 2024-06-30−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure(21.7)Operating income, Q3 FY2024, three months to 2024-09-30−$21.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure47.2Operating income, Q4 FY2024, three months to 2024-12-31$47.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure(37.2)Operating income, Q1 FY2025, three months to 2025-03-31−$37.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(47.6)Operating income, Q2 FY2025, three months to 2025-06-30−$47.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure(53.2)Operating income, Q3 FY2025, three months to 2025-09-30−$53.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure(41.5)Operating income, Q4 FY2025, three months to 2025-12-31−$41.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure(60.1)Operating income, Q1 FY2026, three months to 2026-03-31−$60.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(61.5)Operating income, Q2 FY2026, three months to 2026-06-30−$61.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Net income$m(14.9)Net income, Q3 FY2023, three months to 2023-09-30−$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure(7.2)Net income, Q4 FY2023, three months to 2023-12-31−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Net income, Q1 FY2024, three months to 2024-03-31−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure(12.5)Net income, Q2 FY2024, three months to 2024-06-30−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure(19.1)Net income, Q3 FY2024, three months to 2024-09-30−$19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure49.9Net income, Q4 FY2024, three months to 2024-12-31$49.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure(33.9)Net income, Q1 FY2025, three months to 2025-03-31−$33.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(44.9)Net income, Q2 FY2025, three months to 2025-06-30−$44.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure(51.2)Net income, Q3 FY2025, three months to 2025-09-30−$51.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure(41.3)Net income, Q4 FY2025, three months to 2025-12-31−$41.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure(60.6)Net income, Q1 FY2026, three months to 2026-03-31−$60.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(62.3)Net income, Q2 FY2026, three months to 2026-06-30−$62.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Diluted EPS$ per share(0.16)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figurenot reported(0.11)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure(0.13)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure(0.20)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(0.46)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure(0.52)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figurenot reported(0.61)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(0.63)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Basic EPS$ per share(0.16)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figurenot reported(0.11)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure(0.13)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure(0.20)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figurenot reported(0.35)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(0.46)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure(0.52)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figurenot reported(0.61)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(0.63)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure

Balance sheet

Cash and equivalents$8.2m, Q2 FY2026
Long-term debt$96.7m, Q2 FY2026
Shareholders' equity$12.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m60.5Cash and equivalents, Q3 FY2023, at 2023-09-30$60.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-061996.Report this figure71.0Cash and equivalents, FY2023, at 2023-12-31$71.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0000950170-25-042320.Report this figure56.0Cash and equivalents, Q1 FY2024, at 2024-03-31$56.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-056967.Report this figure36.6Cash and equivalents, Q2 FY2024, at 2024-06-30$36.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0000950170-24-091776.Report this figure39.7Cash and equivalents, Q3 FY2024, at 2024-09-30$39.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure50.8Cash and equivalents, FY2024, at 2024-12-31$50.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figure39.9Cash and equivalents, Q1 FY2025, at 2025-03-31$39.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure51.5Cash and equivalents, Q2 FY2025, at 2025-06-30$51.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure59.6Cash and equivalents, Q3 FY2025, at 2025-09-30$59.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure41.3Cash and equivalents, FY2025, at 2025-12-31$41.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure24.3Cash and equivalents, Q1 FY2026, at 2026-03-31$24.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure8.2Cash and equivalents, Q2 FY2026, at 2026-06-30$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Current assets$m244Current assets, Q3 FY2023, at 2023-09-30$244.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061996.Report this figure232Current assets, FY2023, at 2023-12-31$231.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042320.Report this figure226Current assets, Q1 FY2024, at 2024-03-31$226.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056967.Report this figure221Current assets, Q2 FY2024, at 2024-06-30$220.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091776.Report this figure209Current assets, Q3 FY2024, at 2024-09-30$208.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure334Current assets, FY2024, at 2024-12-31$334.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figure304Current assets, Q1 FY2025, at 2025-03-31$303.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure281Current assets, Q2 FY2025, at 2025-06-30$281.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure339Current assets, Q3 FY2025, at 2025-09-30$338.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure285Current assets, FY2025, at 2025-12-31$284.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure245Current assets, Q1 FY2026, at 2026-03-31$245.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure212Current assets, Q2 FY2026, at 2026-06-30$211.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Total assets$m249Total assets, Q3 FY2023, at 2023-09-30$248.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061996.Report this figure233Total assets, FY2023, at 2023-12-31$233.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0000950170-25-042320.Report this figure228Total assets, Q1 FY2024, at 2024-03-31$227.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056967.Report this figure222Total assets, Q2 FY2024, at 2024-06-30$222.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091776.Report this figure218Total assets, Q3 FY2024, at 2024-09-30$217.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure351Total assets, FY2024, at 2024-12-31$351.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figure327Total assets, Q1 FY2025, at 2025-03-31$327.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure313Total assets, Q2 FY2025, at 2025-06-30$313.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure373Total assets, Q3 FY2025, at 2025-09-30$372.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure328Total assets, FY2025, at 2025-12-31$327.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure288Total assets, Q1 FY2026, at 2026-03-31$287.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure249Total assets, Q2 FY2026, at 2026-06-30$249.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Current liabilities$m11.2Current liabilities, Q3 FY2023, at 2023-09-30$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061996.Report this figure2.4Current liabilities, FY2023, at 2023-12-31$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042320.Report this figure3.7Current liabilities, Q1 FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056967.Report this figure6.7Current liabilities, Q2 FY2024, at 2024-06-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091776.Report this figure16.6Current liabilities, Q3 FY2024, at 2024-09-30$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure23.4Current liabilities, FY2024, at 2024-12-31$23.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figure27.6Current liabilities, Q1 FY2025, at 2025-03-31$27.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure45.6Current liabilities, Q2 FY2025, at 2025-06-30$45.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure50.9Current liabilities, Q3 FY2025, at 2025-09-30$50.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure39.1Current liabilities, FY2025, at 2025-12-31$39.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure49.6Current liabilities, Q1 FY2026, at 2026-03-31$49.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure60.9Current liabilities, Q2 FY2026, at 2026-06-30$60.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Total liabilities$m11.3Total liabilities, Q3 FY2023, at 2023-09-30$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061996.Report this figure2.4Total liabilities, FY2023, at 2023-12-31$2.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0000950170-25-042320.Report this figure3.7Total liabilities, Q1 FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056967.Report this figure6.7Total liabilities, Q2 FY2024, at 2024-06-30$6.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091776.Report this figure16.6Total liabilities, Q3 FY2024, at 2024-09-30$16.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure94.4Total liabilities, FY2024, at 2024-12-31$94.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figure98.3Total liabilities, Q1 FY2025, at 2025-03-31$98.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure121Total liabilities, Q2 FY2025, at 2025-06-30$121.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure225Total liabilities, Q3 FY2025, at 2025-09-30$225.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure213Total liabilities, FY2025, at 2025-12-31$213.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure226Total liabilities, Q1 FY2026, at 2026-03-31$226.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure237Total liabilities, Q2 FY2026, at 2026-06-30$237.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figurenot reportednot reported96.2Long-term debt, Q3 FY2025, at 2025-09-30$96.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure96.4Long-term debt, FY2025, at 2025-12-31$96.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure96.5Long-term debt, Q1 FY2026, at 2026-03-31$96.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure96.7Long-term debt, Q2 FY2026, at 2026-06-30$96.7m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure
Shareholders' equity$m237Shareholders' equity, Q3 FY2023, at 2023-09-30$237.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure231Shareholders' equity, FY2023, at 2023-12-31$230.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001193125-26-097478.Report this figure224Shareholders' equity, Q1 FY2024, at 2024-03-31$223.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure215Shareholders' equity, Q2 FY2024, at 2024-06-30$215.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure201Shareholders' equity, Q3 FY2024, at 2024-09-30$201.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure257Shareholders' equity, FY2024, at 2024-12-31$256.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure229Shareholders' equity, Q1 FY2025, at 2025-03-31$229.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure192Shareholders' equity, Q2 FY2025, at 2025-06-30$192.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure148Shareholders' equity, Q3 FY2025, at 2025-09-30$147.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure114Shareholders' equity, FY2025, at 2025-12-31$114.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure61.3Shareholders' equity, Q1 FY2026, at 2026-03-31$61.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure12.5Shareholders' equity, Q2 FY2026, at 2026-06-30$12.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure

Cash flow

Operating cash flow−$60.9m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-125924. Derived: 9-month figure less the 6-month figure.Report this figure(17.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure(7.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0000950170-25-107618. Derived: 6-month figure less the 3-month figure.Report this figure(14.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273111. Derived: 9-month figure less the 6-month figure.Report this figure42.0Operating cash flow, Q4 FY2024, three months to 2024-12-31$42.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure(40.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$40.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(39.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$39.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349140. Derived: 6-month figure less the 3-month figure.Report this figure(47.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$47.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273111. Derived: 9-month figure less the 6-month figure.Report this figure(43.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$43.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure(44.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$44.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure(60.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$60.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349140. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-125924. Derived: 9-month figure less the 6-month figure.Report this figure(0.1)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$91.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0000950170-25-042320. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0000950170-25-107618. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273111. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$302.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$91.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349140. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$197.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273111. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-097478. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349140. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)99.31m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares30.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3030,755,123 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-061996.Report this figure94.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3194,227,313 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056967.Report this figure94.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3094,911,268 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091776.Report this figure95.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3095,576,627 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-125924.Report this figure96.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3196,486,480 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-070900.Report this figure96.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3096,827,687 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0000950170-25-107618.Report this figure97.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3097,032,331 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure98.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3198,060,636 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure98.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3098,361,771 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure98.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3098,807,600 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273111.Report this figure99.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3199,296,408 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-225142.Report this figure99.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3099,312,526 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure

Shares outstanding: 99.45mShares outstanding, period not labelled, at 2026-08-1199,447,343 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349140.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.